• Ruvistay Gutiérrez-Arias, Yorschua Jalil, Rocío Fuentes-Aspe, and Pamela Seron.
• Physical Medicine and Rehabilitation Service, Critical Care Unit, Instituto Nacional del Tórax, Santiago, Chile; Exercise and Rehabilitation Sciences Institute, School of Physical Therapy, Faculty of Rehabilitation Sciences, Universidad Andres Bello, Santiago, Chile.
• Clinics (Sao Paulo). 2022 Jan 1; 77: 100108.

ObjectiveTo estimate the effectiveness of Neuromuscular Electrostimulation (NMES) in adults with COPD undergoing MV.MethodA sensitive search was performed in MEDLINE, Embase, CENTRAL, CINAHL and other resources. Randomized Controlled Clinical Trials (RCTs) or non-RCTs that enrolled adults with COPD on MV due to an exacerbation of their disease were included. Two independent reviewers screened, extracted information, and assessed the risk of bias (RoB 2 tool) and the certainty of evidence (GRADE approach) from the included studies.ResultsFour RCTs (144 participants) were included. Subjects who underwent NMES were able to move from bed to chair independently in less time (MD = 4.98 days less; 95% CI -8.55 to -1.47; 2 RCTs; low certainty of the evidence) and they were fewer days on MV (MD = 2.89 days less; 95% CI -4.58 to -1.21); 3 RCTs; low certainty of the evidence) than the control group. However, the effect of NMES on muscle strength is unclear (very low certainty of the evidence).ConclusionsNMES may improve functional independence and decrease MV time in adults with COPD; however, its effectiveness on muscle strength is uncertain. More and better RCTs are needed to determine with greater certainty the effectiveness of NMES in this population.Copyright © 2022 HCFMUSP. Published by Elsevier España, S.L.U. All rights reserved.

14 keywords...

hide…